Cardiovascular, cerebrovascular, and hepatic safety of desvenlafaxine for 1 year in women with vasomotor symptoms associated with menopause Article

Industry Collaboration

author list

  • Archer, David F., Pinkerton, JoAnn V., Guico-Pabia, Christine J., Hwang, Eunhee, Cheng, Ru-fong J., Study 3353 Investigators

publication date

  • January 1, 2013

webpage

author keyword

  • Adverse outcomes
  • Cardiovascular
  • Cerebrovascular
  • Desvenlafaxine
  • Hepatic

category

keywords

  • Adverse outcomes
  • Cardiovascular
  • Cerebrovascular
  • Desvenlafaxine
  • Hepatic

start page

  • 47

end page

  • 56

volume

  • 20

issue

  • 1